课题基金 / 基金详情

Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)

Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)
神经科学临床试验卓越网络临床研究网站 (NeuroNEXT)
批准号:
9975920
负责人:
MARK S QUIGG
金额:
$32.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30

项目摘要

项目成果

MARK S QUIGG的其他基金

相似基金

相关文献

中文摘要
翻译
尽管最近取得了进展,但神经系统疾病仍然是一个主要的公共卫生问题,并且不仅在美国而且在世界范围内都是显著发病率和死亡率的来源。随着神经科学新知识的爆炸式增长,整体神经系统疾病负担有可能大幅减少,但将新的实验室发现转化为新的人类治疗方法已经滞后,部分原因是组织,资金和执行必要的人类临床试验效率低下,以证明新治疗方法的有效性。神经科学临床试验卓越网络(NeuroNEXT)的更新旨在帮助加快早期多中心临床试验的进行过程,以建立安全性和剂量信息,或验证生物标志物和临床结果,为中期和晚期疗效试验做准备。本申请建议将弗吉尼亚大学卫生系统更新为NeuroNEXT网络的临床站点。该提案描述了弗吉尼亚大学作为NeuroNEXT研究中心的有效和高效的过去表现,可用于进行NeuroNEXT试验的多学科临床神经病学研究人员的非凡经验和专业知识,一个已经存在的临床外展计划,将为农村少数民族和医疗服务不足的患者群体提供服务,与全州神经病学实践的外展计划,将最大限度地提高整个弗吉尼亚大学,研究基础设施和领导计划,成功执行在弗吉尼亚大学的NeuroNEXT临床试验的集水区招募,以及我们强大的历史和进一步的计划,以指导未来的临床研究人员。
英文摘要
Despite recent advances, neurological diseases continue to be a major public health problem and are the source of significant morbidity and mortality not only in the United States, but world-wide. With the explosion of new knowledge in the neurosciences, the possibility of dramatic reductions in the overall neurological disease burden exists, but translation of new laboratory findings into new human treatments has lagged partially due to inefficiencies in the organization, funding, and execution of the necessary human clinical trials to prove the efficacy of new therapeutic approaches. This renewal for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) is proposed to help expedite the process of the conduct of early phase multi-center clinical trials to establish safety and dose information or to validate biomarkers and clinical outcomes in preparation for middle and late phase trials of efficacy. This application proposes the University of Virginia Health System be renewed as a Clinical Site for the NeuroNEXT network. The proposal describes the effective and efficient past performance of the University of Virginia as a NeuroNEXT site, the extraordinary experience and expertise of a multi-disciplinary cadre of clinical neurological investigators available to conduct NeuroNEXT trials, an already existing clinical outreach program that will afford access to rural minority and medically underserved patient populations, an outreach program with statewide neurology practices that will maximize trial recruitment throughout the catchment of the University of Virginia, the research infrastructure and leadership plan for successfully executing NeuroNEXT clinical trials at the University of Virginia, and our robust history and further plans to mentor future clinical researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)
  • 批准号:
    10593629
  • 项目类别:
  • 资助金额:
    $32.3万
  • 财政年份:
    2018
  • 负责人:
    MARK S QUIGG
  • 依托单位:
Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)
  • 批准号:
    10201769
  • 项目类别:
  • 资助金额:
    $32.3万
  • 财政年份:
    2018
  • 负责人:
    MARK S QUIGG
  • 依托单位:
PATHOPHYSIOLOGICAL BASIS OF LUTEINIZING HORMONE SECRETION PATTERNS IN EPILEPSY
  • 批准号:
    7205501
  • 项目类别:
  • 资助金额:
    $3.7万
  • 财政年份:
    2005
  • 负责人:
    MARK S QUIGG
  • 依托单位:
Chronobiology of partial epilepsy
  • 批准号:
    6539482
  • 项目类别:
  • 资助金额:
    $12.78万
  • 财政年份:
    1997
  • 负责人:
    MARK S QUIGG
  • 依托单位:
海外基金